Inhalon
0 followers
Inhalon Biopharma is developing an inhaled immunotherapy platform for treating acute respiratory infections (ARI), such as syncytial virus (RSV), influenza, metapneumovirus (MPV), parainfluenza virus (PIV), adenovirus, severe acute respiratory syndrome (SARS) and middle east respiratory syndrome (ME... Read more
Org chart
John Whelan
President, CEO & Director
John Whelan
Collapse
Sam Lai
Founder, Chief Scientific Officer & Director
Jeff Hutchins
Chief Development Officer
Bill Picht
Consulting CFO
Thomas Moench
VP, Clinical
Brian Farrer
Senior Director, Development
